Novel Treatment for Diastolic Heart Failure in Women

Completed · Phase 4 · Has a placebo group

Conditions studied: Heart Failure

In brief

The purpose of the study is to collect information about the potential benefit and safety of low dose spironolactone for a patient with diastolic heart failure (DHF) and to determine whether spironolactone can cause the patient's condition to improve.

Key facts

Study ID
NCT00206232
Run by
Baylor College of Medicine
People needed
48
Starts
2004-07-01
Expected to finish
2010-07-01
Last updated by the study team
2013-02-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.